Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tian-Lu Cheng

Showing results (41-50 of 153) with videos related to

Pageof 16
Sort By:
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|November 1, 2008
Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRITing-Jung Chen, Tsan-Hwang Cheng, Chiao-Yun Chen, et al.
Mabs|May 31, 2014
Mimicking the germinal center reaction in hybridoma cells to isolate temperature-selective anti-PEG antibodiesYu-Cheng Su, Talal S Al-Qaisi, Hsin-Yi Tung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2010
Cutting Edge: mechanical forces acting on T cells immobilized via the TCR complex can trigger TCR signalingYa-Chen Li, Bing-Mae Chen, Pei-Chun Wu, et al.
The Journal of Surgical Research|July 17, 2017
Optimization of a multigene biochip for detection of relapsed and early relapsed colorectal cancerYu-Tang Chang, Yung-Sung Yeh, Cheng-Jen Ma, et al.
Oncology Research|December 13, 2016
Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated According to Uridine Diphosphate Glucuronosyltransferase 1A1 Genotyping in Patients With Metastatic Colorectal CancerCheng-Jen Ma, Ching-Wen Huang, Yung-Sung Yeh, et al.
BMC Cancer|July 22, 2009
GLUT1 gene is a potential hypoxic marker in colorectal cancer patientsFu-Yen Chung, Ming-Yii Huang, Ching-Sheng Yeh, et al.
DNA and Cell Biology|November 4, 2011
EVI2B, ATP2A2, S100B, TM4SF3, and OLFM4 as potential prognostic markers for postoperative Taiwanese colorectal cancer patientsMing-Yii Huang, Hwei-Ming Wang, Teck-Siang Tok, et al.
Molecular Pharmaceutics|January 30, 2016
Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor ActivationZeljko M Prijovich, Pierre-Alain Burnouf, Hua-Cheng Chou, et al.
Molecules (Basel, Switzerland)|November 11, 2020
Chemical Constituent of β-Glucuronidase Inhibitors from the Root of <i>Neolitsea acuminatissima</i>Chu-Hung Lin, Hsiao-Jung Chou, Chih-Chi Chang, et al.
Bioconjugate Chemistry|March 30, 2011
A humanized immunoenzyme with enhanced activity for glucuronide prodrug activation in the tumor microenvironmentKai-Chuan Chen, Shih-Yen Wu, Yu-Lin Leu, et al.
Pageof 16

Showing results (41-50 of 153) with videos related to

Sort By:
Pageof 16
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|November 1, 2008
Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRITing-Jung Chen, Tsan-Hwang Cheng, Chiao-Yun Chen, et al.
Mabs|May 31, 2014
Mimicking the germinal center reaction in hybridoma cells to isolate temperature-selective anti-PEG antibodiesYu-Cheng Su, Talal S Al-Qaisi, Hsin-Yi Tung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2010
Cutting Edge: mechanical forces acting on T cells immobilized via the TCR complex can trigger TCR signalingYa-Chen Li, Bing-Mae Chen, Pei-Chun Wu, et al.
The Journal of Surgical Research|July 17, 2017
Optimization of a multigene biochip for detection of relapsed and early relapsed colorectal cancerYu-Tang Chang, Yung-Sung Yeh, Cheng-Jen Ma, et al.
Oncology Research|December 13, 2016
Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated According to Uridine Diphosphate Glucuronosyltransferase 1A1 Genotyping in Patients With Metastatic Colorectal CancerCheng-Jen Ma, Ching-Wen Huang, Yung-Sung Yeh, et al.
BMC Cancer|July 22, 2009
GLUT1 gene is a potential hypoxic marker in colorectal cancer patientsFu-Yen Chung, Ming-Yii Huang, Ching-Sheng Yeh, et al.
DNA and Cell Biology|November 4, 2011
EVI2B, ATP2A2, S100B, TM4SF3, and OLFM4 as potential prognostic markers for postoperative Taiwanese colorectal cancer patientsMing-Yii Huang, Hwei-Ming Wang, Teck-Siang Tok, et al.
Molecular Pharmaceutics|January 30, 2016
Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor ActivationZeljko M Prijovich, Pierre-Alain Burnouf, Hua-Cheng Chou, et al.
Molecules (Basel, Switzerland)|November 11, 2020
Chemical Constituent of β-Glucuronidase Inhibitors from the Root of <i>Neolitsea acuminatissima</i>Chu-Hung Lin, Hsiao-Jung Chou, Chih-Chi Chang, et al.
Bioconjugate Chemistry|March 30, 2011
A humanized immunoenzyme with enhanced activity for glucuronide prodrug activation in the tumor microenvironmentKai-Chuan Chen, Shih-Yen Wu, Yu-Lin Leu, et al.
Pageof 16